Can Anticholinergic Medications Make Movement Disorders Worse?

What’s the Role of Amantadine in Anticholinergic Deprescription?

CME: The Future of Schizophrenia Care: A Closer Look at the Role of Muscarinic Acetylcholine Receptor Activation

CME: Emerging Therapeutic Targets for Schizophrenia: A Focus on Muscarinic Acetylcholine Receptor Activation

Navigating the A to Z of Schizophrenia, Part 3: Novel Treatment Mechanisms

Great Debates: Exploring Muscarinic Agonists in Schizophrenia Treatment

Muscarinic Pathways in Schizophrenia: Unlocking New Therapeutic Targets

CME: Meet Me at the Water Cooler: Schizophrenia

End of the Anticholinergic Era? Challenging Cases in Anticholinergic Deprescribing: Real-World Scenarios (Module 4)

End of the Anticholinergic Era? Deprescribing with Confidence: Strategies for Safe Medication Changes (Module 3)